Diopsys® ARGOS™

Key Features

• Tabletop visual electrophysiology testing device for the clinic.
• Provides objective and functional information about retinal and visual pathway health using intuitive, color-coded results based on documented reference ranges.
• Results from these tests are not just for rare diseases, but also for the management of more common disorders like diabetic retinopathy, glaucoma, and optic neuritis.*
• Diopsys® ERG (pattern electroretinography) - Measures performance of retinal ganglion cells* - Helps identify “stressed” cells at a subclinical stage, when the cells have become dysfunctional but are still alive* - Clinically effective in helping to diatnose and manage disorders including glaucoma, age-related macular degeneration (AMD), and diabetic edema, among others.*
• Diopsys® ffERG / Flicker (flicker electroretinography) - Indicates level of retinal function loss and recovery on patients with retinopathies* - Ability to measure the effect of retinopathies on vision through the presence of cataracts.* - Clinically effective in helping to manage retinal disorders including diabetic retinopathy, CRVO, uveitis, and retinal concerns obscured by media opacities.*
• Diopsys® mfERG (multifocal electroretinography) - Helps recognize the first signs of drug-induced retinopathy* - May indicate retinal dysfunction without structural abnormalities* - Clinically effective in helping to diagnose and manage diseases affecting the retina, most notably retinal toxicities.*
• Diopsys® VEP (visual evoked potential) - Provides objective information on the function of the entire vision system, from the anterior segment of the eye to the visual cortex* - Clinically effective in helping to diagnose and manage neuro-visual disorders such as optic neuritis, amblyopia, and vision problems due to TBI.*
• *References on file with Diopsys and listed on Diopsys.com